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Background & Aims: The role of small intestinal proteo- icy seems to play an important role. However, inclica-
lytic activity in the regulation of upper gastrointestinal 
function in humans is poorly understood. The aim of this 
study was to determine the importance of proteolytic ac­
tivity for protein- or amino acid-induced cholecystokinin 
release and pancreaticobiliary secretion. Methods: In 9 
healthy subjects, saline was perfused intraduodenally for 
3 hours either with or without the synthetic protease 
inhibitor camostate. During the last hour, albumin or 
amino acids in the same molecular composition as albu­
min were also perfused. Results: Perfusion with camos-
tions accumulate that: species differences in feedback 
regulation of pancreaticobiliary secretion complicate ex­
trapolation of animal data to humans.H~u A clear com­
prehension of feedback regulation of pancreaticobiliary 
s ec re t ion i n h umans is of m a j o r i m p o r ta ne e fo r t h e u n d e r - 
s t and ing of clini ca 1 c o n cliti o n s s uc h a s exo c r i n e p a n c re a t i c 
insufficiency and gallstone disease.
The aim of the present study was to investigate the 
importance of protease activity in the regulation of chole-
tate, in concentrations that abolished intraduodenal pro- cystokinin (CCK) release, gallbladder contraction, and 
teolytic activity, had no effect on unstimulated plasma pancreatic exocrine secretion under both basal conditions
cholecystokinin concentrations or gallbladder emptying, and during stimulation with protein (albumin) or an
but markedly (P <  0.05) increased unstimulated pancre- amino acid mixture. For this purpose, protease activity 
atic enzyme output. Perfusion with protein distinctly stim- ¡n the lumen of the small intestine was inactivated in
ulated cholecystokinin release, gallbladder emptying, and 
pancreatic enzyme output (P <  0.05). Perfusion with ca­
mostate resulted in significantly lower protein-stimulated 
plasma cholecystokinin, gallbladder, and pancreatic en­
zyme responses (P <  0.05). Perfusion with amino acids 
also stimulated plasma cholecystokinin, gallbladder emp­
tying, and pancreatic enzyme output (P <  0.05). Camos­
tate did not inhibit these values. Conclusions: This study 
shows that appropriate digestion of protein is required 
to stimulate plasma cholecystokinin release, gallbladder 
emptying, and pancreatic enzyme secretion in humans.
ancreaticobiliary responses to meals, which are es­
sential for the digestion of nutrients, can be classified 
into (1) cephalic responses, which are mainly activated 
by seeing, smelling, chewing, and swallowing of food 
and are primarily induced by vagal cholinergic activity1;
(2) gastric responses, which are activated when food en­
ters the stomach and are principally dependent on local 
cholinergic activity *; and (3) intestinal responses, which 
are activated when food enters the duodenum and are not
only dependent on cholinergic but also on peptidergic nylpropionic acid-succinimide ester (Bolton—Hunter reagent) 
activity/ Intestinal responses are considered to be most from New England Nuclear (Boston, MA); Pharmacia De- 
im por cant for appropriate digestion of nutrients. Regula­
tion of pancreaticobiliary secretion at the intestinal level 
is subjected to feedback control, in which pro tease activ-
sorae of the experiments by perfusing the duodenum 
with camostate, a synthetic protease inhibitor that inacti­
vates proteases including trypsin, chy mo trypsin, phos- 
p ho lipase A:>, and pancreatic kallikre in//,,M
Materials and Methods
Subjects
Nine healthy volunteers (1 woman and H men; mean 
age, 24 ± 3 years) participated in the studies. None of the 
volunteers was caking any medication or had a history of gas­
trointestinal symptoms or surgery. The study protocol was 
approved by the ethical committee of the University Hospital 
Nijmegen, and all subjects gave their written informed consent 
before entering the study.
Reagents
Cam()state was a gift froin Professor G u ido  Adler (U n i­
versity of LJlm, Germany), Radioiodinaced porcine pancreatic
I  I
polypeptide ( “ i-PPP) was obtained from Novo Nordisle AS 
(Bagsvaerd, Denmark); synthetic C C K ** from Peninsula Labo­
ratories Europe, Ltd. (St. Helens, England); [^nhydroxyphe-
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canting Suspension #3 from Pharmacia Diagnostics (Uppsala, 
Sweden); human pancreatic polypeptide, L-amino acids, and 
albumin from Sigma Chemical Co. (Sc. Louis, MO); polyethyl­
ene glycol 4000 from BDH Ltd. (Poole, England); and trypsin 
radioimmunoassay kits from Behring Diagnostica (Amster­
dam, The Netherlands). All other materials were obtained from 
Merck (Amsterdam, The Netherlands).
Study Protocol
After a 12-hour fast, the volunteers presented at the 
laboratory at 7:30 AM. In random order, 4 experiments were 
performed separated from each other by at least 1 week. A 
triple-lumen polyvinyl tube with an outer diameter of 5.7 mm 
was positioned under fluoroscopic control with the proximal 
lumen in the stomach, the middle lumen at the level of the 
ampulla of Vater, and the distal lumen at the ligament of 
Treitz. In addition, an indwelling intravenous catheter was 
placed in a forearm for the collection of blood samples. After 
an equilibration period of at least 30 minutes, the following 
tests were performed.
Study 1. In 9 subjects, polyethylene glycol 4000 (0.6 
g/100 mL saline) was perfused through the middle opening of 
the tube at a rate of 5 mL/min during the entire 3-hour study 
period. Camostate (0.6 g/h) was added to this solution during 
the last 2 hours of the test. During the last hour of the test, 
albumin (15 g/h, 330 mosmol/L) was also perfused intraduode­
nally through the middle opening of the tube (Figure 1).
Study 2. The protocol of study 2 was comparable with 
that of study 1; however, in this experiment, 15 g of albumin 
without camostate was perfused intraduodenally in the 9 sub­
jects during the last hour of the test (Figure 1).
saline + P E G -4000
camostate (test 1 and 3)
albumin or AA
*  *  * * * * * * * * *
I r I I [ i J I I t  L l  I
-60 -30 0 30 60 90 120
Time (min)
Figure 1. Study protocol for the different experiments in studies 1-4. 
In study 1 (9 subjects), saline (300 mL/h) was continuously perfused 
Intraduodenally with the recovery marker polyethylene glycol 4000 
(1.8 g/h) for 3 hburs. During the last 2 hours of the test, the protease 
inhibitor camostate (0.6 g/h) was added to saline, whereas albumin 
(15 g) was added to saline during the last test hour. In study 2 (9 
subjects), albumin was perfused during the last test hour without 
camostate. In studies 3 and 4 (6 subjects), the same experiments 
as in studies 1 and 2 were performed. However, instead of albumin, 
amino acids were perfused. Asterisks denote time points when blood 
was drawn and ultrasonography was performed. Duodenal juice was 
collected during each 15-minute period by spot sampling,
Table 1. Amino Acid Content of the Albumin Meal
Amino acid Content (mmoi)a
Alanine 8.9
Arginine 5.3
Aspartic acid 10.5
Cysteine 3.3
Glutamic acid 14.4
Glycine 3.0
Histidine 3.3
Isoleucine 2.5
Leucine 12.0
Lysine 14.0
Methionine 0.7
Phenylalanine 5.1
Proline 5.3
Serine 5.1
Threonine 6.2
Tryptophan 0.4
Tyrosine 3.6
Valine 6.4
^Amount of amino acids (mmol) in 15 g of the albumin meal.
Study 3. The protocol of study 3 was also comparable 
with that of study 1; however, instead of albumin, 15 g of an 
L-amino acid solution (330 mosmol/L) in the same molecular 
composition as in albumin (Table 1) was perfused intraduode­
nally in 6 of the 9 subjects (6 men; 24 ± 1 years of age) 
during the last hour of the test (Figure 1).
Study 4. The protocol of study 4 was comparable with 
that of study 3 but, in this experiment, 15 g of the L-amino 
acid mixture without camostate was perfused intraduodenally 
in the 6 subjects of study 3 during the last hour of the test
(Figure I).
In all tests, gastric acid was continuously drained through 
the proximal opening of the tube by intermittent negative 
pressure.
Five-milliliter samples of duodenal contents were taken dur­
ing 15-minute periods from the cip of the tube by spot sam­
pling14 and kept on ice. Blood samples were taken every 30 
minutes during the first hour and subsequently every 15 min­
utes until the end of the test period (Figure 1).
Blood was collected in ice-chilled glass tubes containing 2 
g/L of ethylenediaminetetraacedc acid. After the experiments 
were performed, the blood samples were centrifuged at 4°C 
for 10 minutes at 3000g,
Plasma and duodenal samples were stored at —20°C until 
assayed for CCK, pancreatic polypeptide, or polyethylene gly­
col 4000, bilirubin, amylase, trypsin, and chymotrypsin. Each 
time a blood sample was drawn, two longitudinal and two 
transverse images of the gallbladder were obtained by real­
time ultrasonography.
To determine if camostate affects amylase concentrations in 
vitro, 4 mL of duodenal juice obtained in 5 subjects during amino 
acid perfusion was divided into 2 samples of 2 mL each and 
incubated at 37°C for 30 minutes with or without 2 mg/mL of 
camostate. Subsequently, the samples were put on ice for another 
60 minutes and frozen until assayed for amylase activity.
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Plasma Samples
Plasma CCK was measured by a sensitive and specific
Statistical Analysis
All measurements were performed in duplicate, and
radioimmunoassay as described previously.15,16 The antibody the mean of these two measurements was used for further 
used (T204) binds to biologically active CCK peptides con- analysis of results. Gallbladder volume was expressed in millili- 
taining the sulfated tyrosine region with almost equal affinity. ters. Integrated plasma CCK, pancreatic polypeptide, and gall­
on a molar base, sulfated gastrins cross-reacted <2% in the bladder responses were determined by calculating the area 
assay, whereas no cross-reactivity with unsulfated gastrins or under the CCK, pancreatic polypeptide, or gallbladder contrac- 
structurally unrelated peptides was found. The detection limit tion time curves. Subsequently, incremental CCK, pancreatic 
of the assay was between 0.5 and 1.0 pmol/L CCK in plasma. polypeptide, and gallbladder responses to the various stimu- 
The intra-assay precision ranged from 4.6% to 11.5% in the lants were calculated by subtracting the integrated response 
steep part of the standard curve. All measurements of plasma in the basal period (0-60 minutes) from the integrated re-
CCK levels were performed in the same run.
Plasma pancreatic polypeptide levels were also determined 
by radioimmunoassay.17 The antibody used showed no cross-
sponse in the period of stimulation (60-120 minutes) in each 
experiment. Similarly, incremental bilirubin, amylase, and 
trypsin outputs were calculated by subtraction of the total
reactivity with structurally related gastrointestinal regulatory output in the basal period (0-60 minutes) from the total 
peptides, such as peptide YY or neuropeptide Y, or with struc- output in the period of stimulation (60-120 minutes).
rurally unrelated peptides. The detection limit of the assay Results are expressed as mean ± SEM. Statistical analysis
was 0.5 pmol/L of incubation mixture. The intra-assay varia- was performed by two-way analysis of variance (trypsin output 
tion ranged from 4% to 7% in the steep part of the standard after logarithmical transformation) and subsequently by least 
curve. All measurements of plasma pancreatic polypeptide lev- significant difference test or by Student's t test for paired re­
els were performed in one run.
Duodenal Samples
Duodenal samples were analyzed for polyethylene glycol 
4000,IH bilirubin,19 amylase activity,20 and trypsin concentra­
tions. Trypsin concentrations in the duodenal samples were mea­
sured by a commercially available radioimmunoassay kit,21 For 
measurement of trypsin concentrations, the duodenal samples 
were diluted with assay buffer finally containing 2 mg/L of 
camostate. Camostate did not displace radiolabeled trypsin from 
the antibody, and the addition of camostate to the standard 
trypsin solution resulted in an identical standard curve as with- 0,3 pmol/L) and pancreatic polypeptide (20 ± 3 pmol/ 
out camostate (data not shown). Flow rates passing the distal L) levels (Table 2). Both the albumin and amino acicl
suits. When appropriate, the method of Bonferroni was used 
to correct for multiple testing. Differences with a two-tailed 
P value of <0.05 were considered significant.
Results
Plasma Concentrations of CCK and
Pancreatic Polypeptide
Plasma CCK and pancreatic polypeptide time 
curves are shown in Figures 2 ancl 3. Perfusion of camo­
state did not significantly influence basal CCK (2.3 ±
duodenal sampling site were calculated based on known perfu­
sion rates and polyethylene glycol 4000 concentrations at the 
perfusion and sampling ports.11 Outputs of bilirubin, trypsin, 
and amylase were calculated from the product of concentrations 
or activity and flow rates. In basal duodenal samples taken in 
the 15-minute period before and from 45 to 60 minutes after 
the start of albumin perfusion with or without camostate, tryp- 
sin and chymotrypsin activity was determined.“ ’ In these sam­
ples, amino acid analysis was also performed by ion-exchange 
chromatography“' on an amino acid analyzer (Sykam S432) ac-
meai induced significant (P <  0.05) increases of plasma 
CCK to 3.0 ± 0.4 pmol/L and 4.1 ± 0.5 pmol/L (Figure
2) and of plasma pancreatic polypeptide to 30 ± 3 pmol/ 
L and 44 ± 4 pmol/L (Figure 3), respectively. Camostate 
abolished (P <  0.05) incremental plasma CCK and pan­
creatic polypeptide responses to albumin perfusion but 
was without effect on incremental CCK and pancreatic 
polypeptide responses to the amino acid meal (Table 3). 
Incremental CCK and pancreatic polypeptide values in
cording to the procedure from the manufacturer (Analytica bv; the amino acid experiments were higher than in the
Rijswijk, The Netherlands), Ninhydrin reagent was used, and albumin experiment, but in the case of CCK, this differ-
the ninhydrin-amino acid adduct was quantified with an ab- ence failed to reach statistical significance, 
sorbance detector (Uvis 205; Lineair, Analytica bv, Rijswijk,
The Netherlands). Gallbladder Volume and Bilirubin Output
Gallbladder Ultrasonography Camostate clid not significantly influence basal
T . j . a . f i 1 1 1 1 1 1  gallbladder volume or bilirubin output (Figures 4 and 5
Longitudinal and transverse images or the gallbladder °  r °
were obtained by real-time ultrasonography (Sonolayer Sal 77- and Table Perfusion of albumin or amino acids with-
B; Toshiba, Tokyo, Japan) using a 3.75-MHz transducer.25’26 out camostate induced a statistically significant decrease
Gallbladder volume was calculated from these images by the of gallbladder volume (P <  0.001) that was accompanied 
sum of cylinders method using a computer system.27 The varia­
tion of volume measurements ranged from 6% to 22%.
by a significant (P <  0.05) increase of bilirubin output 
into the duodenum (Figures 4 and 5). Camostate com-
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pletely inhibited incremental gallbladder contraction and 
bilirubin output in response to albumin (P <  0.05) but 
not to amino acids (Table 3). Gallbladder and bilirubin 
responses to amino acids with and without camostate 
were higher than those to albumin with and without 
camostate, but in the case of bilirubin output, this differ­
ence failed to reach statistical significance.
Pancreatic Enzyme Output
Perfusion of camostate markedly (P <  0.05) in­
creased basal trypsin and amylase output when compared 
with saline (Figure 6 and Table 2). In the albumin experi­
ments, camostate significantly (P <  0.05) inhibited in­
cremental trypsin output and reduced incremental amy­
lase output when compared with albumin perfusion alone 
(Table 3). Incremental trypsin and amylase outputs dur­
ing perfusion of amino acids were not influenced by
camostate.
Trypsin and Chymotrypsin Activity
Trypsin and chymotrypsin at the end of the last 
test hour (105 — 120 minutes) were 1.13 ± 0.62 and
0.34 ±0.11 kU/L, respectively, during perfusion of al­
bumin without camostate, whereas they were below the
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Figure 2. Plasma CCK (pmol/L) in response to intraduodenal perfu­
sion of (4) 15 g of albumin in 9 healthy subjects or (B) 15 g of amino 
acids in 6 healthy subjects with (open symbols) or without (closed 
symbols) the protease inhibitor camostate. Results are expressed as 
mean ± SEM.
Time (min)
Figure 3. Plasma pancreatic polypeptide (pmol/L) in response to in­
traduodenal perfusion of (>4) 15 g of albumin in 9 healthy subjects or 
(S) 15 g of amino acids in 6 healthy subjects with (open symbols) or 
without (closed symbols) the protease inhibitor camostate. Results 
are expressed as mean ± SEM.
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Table 2. Integrated Responses in the Basal Period (0 -6 0
Minutes)
Without camostate With camostate
CCK (pmol/L • 60 min) 137 ± 16 128 ± 16
Pancreatic polypeptide 1246 ± 104 1318 ± 214
(pmol/L • 60 min)
9
Gallbladder contraction —34 ± 51 18 ± 55
(.mL • 60 min)
Bilirubin (fimol) 15.2 ± 4.8 16.3 ± 5.0
Trypsin (fig) 216 ± 43a 633 ± 128
Amylase (kU) 5.1 ± 0.8a 7.2 ± 1.2
NOTE. Integrated responses to intraduodenal perfusion of saline with 
or without camostate in the basal period (0-60 minutes) in 9 sub­
jects. Results are expressed as mean ± SEM.
^Significantly different (P < 0.05) from camostate.
detection lim it (<0.01 kU/L) of the assays (P <  0.01) 
when albumin was perfused with camostate.
Amino Acid Analysis
9
Before and at the end of albumin perfusion experi­
ments, an additional duodenal juice sample was obtained 
for amino acid analysis. During albumin perfusion, high 
amounts of free amino acids were detectable, whereas
*
during addition of camostate to the albumin solution, 
almost no free amino acids were present (P <  0.001 for 
all amino acids measured; Table 4).
In Vitro Amylase Activity
Amylase activity in the 5 duodenal samples ob­
tained during perfusion of the duodenum with amino 
acids was 38.4 ± 8.4 kU/L. Addition of camostate to 
these samples did not significantly affect amylase activity
(41.0 ± 8.8 kU/L).
Discussion
I
In the present study, we have shown that the 
synthetic protease inhibitor camostate inhibits CCK re­
lease, pancreatic polypeptide release, gallbladder motil­
ity, and pancreatic enzyme secretion in response to intra- 
duodenally perfused albumin. Camostate by itself is not 
responsible for the observed effects because camostate did 
not affect these parameters in response to an amino acid 
mixture in the same molecular composition as in albu­
min. Camostate almost abolished trypsin and chymotryp- 
sin activity in the lumen of the small intestine not only 
under basal conditions but also during perfusion of albu­
min. The very low concentrations of free amino acids 
measured in the duodenal samples during perfusion of 
albumin with camostate are thus explained by impaired 
proteolysis of albumin. We therefore conclude that diges­
tion of protein is of crucial importance for stimulation of 
CCK release, pancreatic polypeptide release, gallbladder 
contraction, and pancreatic enzyme secretion in humans.
These findings are in line with the observation that 
inactivation of lipase activity in the lumen of the small 
intestine by the synthetic lipase inhibitor tetrahydrolip- 
statin inhibits CCK release in response to unhydrolysed 
fat and alters biological functions of the hormone, such as 
biliary output, pancreatic enzyme secretion, and gastric 
emptying.28 In dogs, amino acids or fatty acids were also 
found to be more effective than intact proteins or fat in 
stimulating pancreatic exocrine secretion.29,'° This mech­
anism is different in rats, in which only intact proteins, 
but not amino acids, stimulate the release of CCK and 
pancreatic exocrine secretion.12’^ 1
Inactivation of protease activity in the lumen of the 
human small intestine by camostate under basal condi­
tions resulted in a significant increase of amylase and 
trypsin output but did not stimulate gallbladder contrac­
tion and plasma CCK release. Addition of camostate to 
duodenal samples did not significantly influence amylase 
concentrations. This excludes the possibility that the in­
crease of amylase concentrations during camostate perfu­
sion was the result of impaired autodigestion of amylase
t
Table 3. Incremental Integrated Responses
Albumin Albumin + camostate Amino acids Amino acids + camostate
CCK {pmoi/L - 60 min) 27.0 ± 6.3° 18.4 ± 10.0 58.1 ± 17.6* 49.0 ± 6.8a
Pancreatic polypeptide 245 ± 71° 29 ± 66 978 ± 131a,b 1155 ± 115^
(pmol/L' 60 min)
Gallbladder contraction 504 ± 116a 110 ± 50 871 ± 123a,ü 744 ± 81a,b
[mL' 60 min)
Bilirubin (/imol) 32.3 ± 9.4a, -1 .3  ± 4.6 45.2 ± 17.7a 61.6 ± 12.9a
Trypsin (/ig) 903 ± 192a 383 ± 123 836 ± 166a 876 ± 304
Amylase (kU) 3.7 ± 1.7 1.3 ± 0.8 2.9 ± 0.6 3.9 ± 0.8
NOTE. Incremental responses to intraduodenal perfusion of albumin or amino acids with or without camostate in 6 subjects. Incremental 
responses were obtained after subtraction of integrated values in the basal period (0-60 minutes) from integrated values in the period of 
stimulation (60-120 minutes). Results are expressed as mean ± SEM.
Significantly different (P < 0.05) from albumin with camostate.
^Significantly different (P < 0.05) from albumin without camostate.
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by inhibition of protease activity.9,32 This supports the has not only been shown under basal conditions but also
hypothesis that at' least under unstimulated conditions, after stimulation with a meal,4,7,35 However, the present
feedback regulation between pancreatic enzyme secretion study is inconsistent with this hypothesis because camo-
and protease activity in the lumen of the small intestine state did not enhance albumin- or amino acid—stimu-
is operative in humansB~10,33 as well as in other species lated CCK release. Methodological differences between 
such as rats.7,34,35 However, in contrast with rats,7,35 pro- previous studies and the present study may have contrib- 
tease-dependent feedback regulation of pancreatic exo- uted to these conflicting results concerning the role of
crine secretion under basal conditions in humans is prob­
ably not mediated by CCK but by cholinergic activity.10
protease activity in the lumen of the human small intes­
tine and CCK release. In contrast with our study, CCK
CCK-dependent negative feedback regulation between was not measured31 or measured by different tech-
intraluminal contents and pancreatic exocrine secretion
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niques or less specific antibodies32 and endogenous 
protease activity was not inactivated by camostate33,34 or 
suppressed by perfusing bovine trypsin into the duode­
num.4 The latter study shows that proteases can inhibit
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Figure 4. Gallbladder volumes (mL) in response to intraduodenal per­
fusion of (v4) 15 g of albumin in 9 healthy subjects or (B) 15 g of 
amino acids in 6 healthy subjects with (open symbols) or without 
(closed symbols) the protease inhibitor camostate. Results are ex­
pressed as mean ± SEM.
Time (min)
Figure 5. Bilirubin output (nmol/15 min) in response to intraduodenal 
perfusion of (4) 15 g of albumin in 9 healthy subjects or (B) 15 g of 
amino acids in 6 healthy subjects with (open symbols) or without 
{closed symbols) the protease inhibitor camostate. Results are ex­
pressed as mean ± SEM.
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Figure 6. [A and B) Trypsin output (}ig/15 min) and (C and D) amyiase output (kU/15 min) in response to intraduodenal perfusion of {A and 
C) 15 g of albumin in 9 healthy subjects or (S and D) 15 g of amino acids in 6 healthy subjects with (open symbols) or without (closed symbols) 
the protease inhibitor camostate. Results are expressed as mean ± SEM.
CCK release, whereas the present study shows that inhi- phenylalanine, and valine, which were potent stimuli of
bition of proteases does not stimulate CCK release. exocrine pancreatic secretion,42,43 was 0.8, 3-1, 4.0, and
Because we and others have shown that CCK release 7.7 mmol/h, respectively. The amounts of the individual 
and gallbladder contraction in response to intraduodenal amino acids present in our albumin and amino acid meal
administration of a meal or bombesin are augmented by,, 
sequestration of bile acids11,36-39 but not by protease 
inactivation, we believe that CCK-mediated feedback 
control of pancreaticobiliary secretion in. humans is prin­
cipally regulated by bile acids and not by protease activ- 
10 36
lty »
Protein and fat are the major constituents of a meal 
that stimulate CCK release, pancreatic exocrine secretion, 
and gallbladder contraction.39”41 In a meal that was iso­
nit rogenous to 18 g of beef hydrolysate, the amount 
of the individual amino acids tryptophan, methionine,
(0.4, 0.7, 5.1, and 6.4 mmol/h, respectively) were compa­
rable. These results confirm that CCK is important for
i
stinÄ ulating pancreaticobiliary secretion in humans at nu­
trient quantities comparable with a regular meal,39,43 
The present findings, together with the report that 
lipolysis is essential to stimulate CCK release and gall­
bladder contraction in humans,28 provide an explanation 
for our findings in patients with exocrine pancreatic in­
sufficiency in which impaired postprandial release of 
CCK and gallbladder motility are restored by supple­
mentation of pancreatic enzymes.44 The present data also
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Table 4. Increments (Mean ± SEM) of Intraduodenal Free
Amino Acid Concentrations in Response to an 
Albumin Meal With or Without Camostate
Amino acid Albumin Albumin + camostate
Threonine 1963 ± 414 163 ± 62
Serine 1420 ± 303 144 ± 46
Aspartic acid 708 ± 135 33 ± 20
Glutamic acid 1599 i 334 82 ± 36
Proline 579 -f- 145 150 ± 68
Glycine 226 H“ 86 115 ± 41
Alanine 2836 -4*- 635 278 ± 64
Valine 3397 ± 744 192 ± 42
Cysteine 391 i 79 12 ± 6
Methionine 612 -h93 37 ± 12
Isoleucine 1189 231 61 ± 18
Leucine 6073 1186 302 ± 69
Tyrosine 2727 rt 809 78 ± 23
Phenylalanine 4420 ± 858 154 ± 42
Lysine 7108 4" 1426 173 ± 32
Histidine 1248 246 54 ± 16
Arginine 3664 -1- 721 90 ± 20
Tryptophan* + + + + + +
NOTE. Values expressed as (imol/L. 
3Not quantitatively tested.
provide an explanation for our experiences in patients 
with celiac disease and a flat jejunal mucosa in which 
CCK release and gallbladder contraction are also im­
paired in response to an ordinary meal but not to a 
predigested meal."15,46
In conclusion, the present study shows that intraduo- 
denal stimulation of CCK release, gallbladder contrac­
tion, and pancreatic enzyme secretion is dependent on 
digestion of protein. Undigested protein only weakly 
stimulates pancreatic enzyme output and does not sig­
nificantly stimulate CCK release and gallbladder contrac­
tion, whereas digested protein markedly stimulates the 
release of CCK, gallbladder contraction, and pancreatic 
enzyme output.
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